Acinetobactin
Acinetobactin is a bifunctional siderophore secreted by Acinetobacter baumannii that competitively binds ferric iron ions. Acinetobactin supplies A. baumannii by sequestering host-sequestered Fe3+, while competitively depriving skin and respiratory commensal bacteria of iron resources, thereby exerting growth-inhibitory effects on Staphylococcus epidermidis, Staphylococcus hominis, Staphylococcus haemolyticus, and Corynebacterium striatum. The synthesis and transport of Acinetobactin enhance the intracellular epithelial colonization ability of A. baumannii, induce apoptosis of host epithelial cells, and simultaneously improve the survival and invasion capabilities of the bacterium in Galleria mellonella and mouse sepsis models. Acinetobactin can be used in A. baumannii-related research.
For research use only. We do not sell to patients.
- CAS No.: 160472-93-5
- Formula: C16H18N4O5
- Molecular Weight:346.34
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
All Endogenous Metabolite Isoforms
More
Biological Activity
Description
In Vitro
Acinetobactin is produced by Acinetobacter baumannii 17978, and specifically diffuses into the inhibition zone of Staphylococcus epidermidis ATCC 12228 only under iron-limiting conditions. It inhibits the growth of Corynebacterium striatum ATCC 6940 and Staphylococcus hominis, exhibits iron ion dependence, and forms a significantly larger inhibition zone under iron-limiting conditions[1].
Acinetobactin is a key factor mediating the inhibition of human Staphylococcus and Corynebacterium striatum ATCC 6940 by Acinetobacter baumannii AB5075 under iron-limiting conditions[1].
Acinetobactin-mediated iron uptake (5 × 103 bacterial cells; 3 h) enables A. baumannii ATCC 19606T to survive within human alveolar epithelial cell line A549, with intracellular CFU counts of the biosynthesis-deficient (s1) and transport-deficient (t6) mutant strains reduced by 2.7-fold and 12-fold, respectively[2].
Acinetobactin-mediated iron uptake is essential for the colonization and survival of A. baumannii ATCC 19606T in the cytoplasm of human alveolar epithelial cell line A549[2].
Acinetobactin-mediated iron uptake enables A. baumannii ATCC 19606T to induce apoptosis in human alveolar epithelial cell line A549[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
In Vivo
Acinetobactin (1.7 × 106 - 3.1 × 106 CFU; intraperitoneal injection) mediates an intact iron uptake system that acts as a core essential component for Acinetobacter baumannii ATCC 19606T to colonize and induce lethal infection in a mouse sepsis model; impaired biosynthesis of acinetobactin reduces virulence, while impaired transport function abolishes lethal virulence at high inoculum doses[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Galleria mellonella (final-instar larvae, mass 250-350 mg)[2]
-
Dosage:1 × 102 CFU; 1 × 105 CFU
-
Administration:injection into hemocoel at last left proleg
-
Result:Exhibited 2.2-fold and 5.0-fold higher bacterial loads in larvae at 18 h compared to the acinetobactin biosynthesis mutant (s1) and transport mutant (t6), respectively.
Caused > 50% larval death by day 6 at 1 × 105 CFU, while the s1 mutant showed intermediate virulence and the t6 mutant killed significantly fewer larvae.
Caused 20% larval death by day 6 at 1 × 102 CFU, while the s1 and t6 mutants showed no significant killing.
Restored killing rates of both mutants to levels comparable to the parental strain when 100 μM FeCl3 was added to inocula.
Restored comparable low-level killing by all strains when 100 μM FeCl3 was added to inocula at 1 × 102 CFU.
-
Animal Model:C57BL/6 (female, 14-16 weeks old)[2]
-
Dosage:ATCC 19606T: 1.7 × 104, 1.0 × 105, 1.9 × 106
s1: 2.0 × 104, 1.0 × 105, 3.0 × 106
t6: 2.9 × 104, 3.5 × 105, 3.1 × 106 -
Administration:i.p.
-
Result:Resulted in a median spleen bacterial load of log10 8.6 CFU/g tissue at 16 h postinfection, which was significantly higher than the median loads of log10 7.3 CFU/g (s1 mutant) and log10 5.7 CFU/g (t6 mutant).
Killed all mice by 24 h at 1.9 × 106 CFU, while 66.7% of mice infected with 3.0 × 106 CFU of the s1 mutant died with a mean time to death of 36.0 h, and no mice infected with 3.1 × 106 CFU of the t6 mutant died over 7 days.
Caused 33.3% mortality at 1.0 × 105 CFU and 0% mortality at 1.7 × 104 CFU; all lower inocula of the s1 and t6 mutants caused 0% mortality.
Chemical Information
-
CAS No. 160472-93-5
-
Molecular Weight 346.34
-
Formula C16H18N4O5
-
SMILES
O=C(C1=C(C(O)=CC=C1)O)N[C@@H]2C(N(O[C@H]2C)CCC3=CN=CN3)=O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
TUNEL staining for apoptotic DNA fragmentation
TUNEL staining detects DNA strand breaks by using terminal deoxynucleotidyl transferase to add labeled nucleotides to exposed 3′-OH DNA termini, generating either microscopic staining in fixed cells or tissue sections, or fluorescence/cytometric signal in cell suspensions. TUNEL positivity reflects DNA fragmentation but should not be interpreted alone as definitive apoptosis, because TUNEL can also label necrotic, autolytic, mechanically damaged, or DNA-repair-associated DNA breaks.
-
LPS-Induced Endotoxemia/Systemic Inflammation
Lipopolysaccharide (LPS)-induced endotoxemia is a widely used in vivo model of acute systemic inflammation in which LPS, a Gram-negative bacterial endotoxin, activates innate immune signaling primarily through TLR4, leading to rapid and transient induction of pro-inflammatory cytokines such as TNF-α, IL-6, and IL-1β in circulation and tissues. This cytokine surge is commonly used as a measurable readout of systemic inflammatory activation and immune dysregulation, and is typically assessed within hours after intraperitoneal LPS administration in mouse models of endotoxemia. The model captures key features of systemic inflammatory response syndrome, including cytokine release, immune cell activation, and downstream tissue responses, and has been used to evaluate anti-inflammatory interventions such as cytokine modulation, lipid mediators, and immune cell-targeting therapies.
-
Annexin V plus membrane-impermeant dye apoptosis staining
Annexin V-based apoptosis assays rely on the detection of phosphatidylserine (PS) externalization from the inner leaflet of the plasma membrane to the outer leaflet, an early biochemical hallmark of apoptosis. Fluorescently labeled Annexin V binds PS in a calcium-dependent manner, enabling identification of early apoptotic cells by flow cytometry or fluorescence microscopy. When combined with a membrane-impermeant DNA-binding dye (e. g. , propidium iodide), this approach allows discrimination between viable (Annexin V−/dye−), early apoptotic (Annexin V+/dye−), and late apoptotic or necrotic (Annexin V+/dye+) cell populations by assessing membrane integrity and PS exposure.
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
-
Cell invasion
Cell invasion is the ability of cells to migrate from one area to another via the extracellular matrix. Cell invasion is the response of normal and cancer cells to chemical and mechanical stimuli. Before migrating to a new region, the extracellular matrix is degraded by proteases within the cell. Cell invasion often occurs during wound repair, vascularization and inflammation, abnormal tissue invasion, and tumor cell metastasis.
-
Perls' Prussian Blue Iron Staining
Perls' Prussian blue staining is a histochemical method used to detect non-heme ferric iron (Fe3+) in biological tissues by exploiting an acid-mediated release of loosely bound iron from storage complexes such as ferritin or hemosiderin, followed by its reaction with potassium ferrocyanide to form an insoluble blue ferric ferrocyanide (Prussian blue) precipitate that marks iron localization under light microscopy. The reaction is classically performed under acidic conditions, which liberate Fe3+ ions that subsequently bind ferrocyanide to generate the visible chromogen, enabling spatial visualization of iron deposits in tissues such as brain, liver, and spleen. Histochemical interpretations are limited to a reactive iron pool rather than total iron content, reflecting only histologically accessible iron species rather than tightly protein-bound iron.
Purity & Documentation
References
[1]. Knauf GA, et al. Acinetobactin-Mediated Inhibition of Commensal Bacteria by Acinetobacter baumannii. mSphere. 2022 Feb 23;7(1):e0001622. [Content Brief]
[2]. Gaddy JA, et al. Role of acinetobactin-mediated iron acquisition functions in the interaction of Acinetobacter baumannii strain ATCC 19606T with human lung epithelial cells, Galleria mellonella caterpillars, and mice. Infection and immunity. 2012 Mar;80(3):1015-24. [Content Brief]
[3]. Yamamoto S, et al. Isolation and structure elucidation of acinetobactin, a novel siderophore from Acinetobacter baumannii. Archives of microbiology. 1994;162(4):249-54. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Keywords
- Acinetobactin
- 160472-93-5
- Endogenous Metabolite
- A. haemolyticus ATCC 17906
- Staphylococcus epidermidis
- Acinetobacter baumannii ATCC 19606
- A549 human alveolar epithelial cells
- Corynebacterium striatum
- Galleria mellonella larvae
- Staphylococcus haemolyticus
- Staphylococcus hominis
- nosocomial infections
- human alveolar epithelial cells
- Inhibitor
- inhibitor
- inhibit